ImmunoMet Therapeutics

About:

ImmunoMet Therapeutics is a biopharmaceutical company that develops and commercializes oncology products for cancer patients.

Website: http://immunomet.com/

Top Investors: SL Investment, Mirae Asset Venture Investment, InterVest, G.N. Tech Venture, Aju Tech

Description:

ImmunoMet Therapeutics is a development-stage biopharmaceutical company focused on the development and commercialization of novel oncology products that are aimed to improve the quality of life of cancer patients. With more than 6 years of experience in the field of cancer metabolism and immunometabolism, ImmunoMet has developed a comprehensive pipeline of metabolic regulators preferentially targeting the cellular metabolism of drug-resistant cancer subpopulations and immuno-suppressors of anti-cancer effector T cells.